Markets
BSE See NSE See 49,206.47
256.71 (0.52%)

Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection

Anthony Fernandes / Article rating: 4.0

On Thursday, Caplin Point Laboratories announced that its subsidiary, Caplin Steriles Limited has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Neostigmine Methylsulfate injection.   

First2345791011Last

Get A Call From Industry Experts

Send Otp

   I authorize DSIJ Pvt Ltd to contact me. This will override registry on the NDNC.

DSIJ MINDSHARE

12345Last

Knowledge

12345Last